Kerul Patel

Kerul's idea of relaxation is a brisk run of about four kilometers, even in India's notoriously hot and steamy weather. Kerul has a rare and dangerous form of bone marrow cancer-chronic myeloid leukemia (CML)-but says "I can lead a near-normal life" thanks to my treatment with one of the world's most advanced cancer medications from Novartis.

After being diagnosed Kerul remembers being on an emotional roller-coaster-worried about the disease, worried about his family, and worried about the cost of advanced treatment, which Kerul knew he could not afford. Kerul's doctor told him about GIPAP™ from Novartis Oncology.

Through GIPAP Kerul, and more than 34,500 other patients worldwide, have received this medication free of cost to the patient or the government. GIPAP helps patients in 80 countries who are not insured, not reimbursed, cannot pay for treatment privately.

Kerul is deeply appreciative of Novartis Oncology-for developing his advanced cancer treatment and for making it available at no charge to so many people in need around the world.